MedPath

Reiley Pharmaceuticals, Inc.

Reiley Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2014-01-01
Employees
1
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

[Tc-99m]-RPI-087 as an Imaging Marker in Osteoarthritis of the Knee Compared to Healthy Volunteers

Phase 1
Conditions
Healthy
Osteo Arthritis Knee
Interventions
Drug: [Tc-99m]-RPI-T-087 Injection
First Posted Date
2018-04-20
Last Posted Date
2019-01-15
Lead Sponsor
Reiley Pharmaceuticals Inc.
Target Recruit Count
24
Registration Number
NCT03503825
Locations
🇨🇦

St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.